Cargando…

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer

BACKGROUND: In recent years, immune-associated genes (IAGs) have been documented as having critical roles in the occurrence and progression of muscle-invasive bladder cancer (MIBC). Novel immune-related biomarkers and a robust prognostic signature for MIBC patients are still limited. The study is ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Chengquan, Xu, Ting, Sun, Yefeng, Wang, Liping, Liang, Zhijuan, Niu, Haitao, Jiao, Wei, Wang, Yonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785346/ https://www.ncbi.nlm.nih.gov/pubmed/33456631 http://dx.doi.org/10.1155/2020/8866730

Ejemplares similares

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA
por: Shen, Chengquan, et al.
Publicado: (2020)

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
por: Sun, Ningchuan, et al.
Publicado: (2019)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
por: Ma, Chengquan, et al.
Publicado: (2016)

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
por: Shen, Chengquan, et al.
Publicado: (2021)

Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy
por: Zhao, Ming, et al.
Publicado: (2020)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer
por: Chu, Guangdi, et al.
Publicado: (2023)

Stromal proteome expression profile and muscle-invasive bladder cancer research
por: Niu, Haitao, et al.
Publicado: (2012)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer
por: Du, Xiaoyi, et al.
Publicado: (2022)

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2023)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Proteomics research on muscle-invasive bladder transitional cell carcinoma
por: Niu, Hai Tao, et al.
Publicado: (2011)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer
por: Wang, Yonghua, et al.
Publicado: (2018)

Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer
por: Zhou, Lin, et al.
Publicado: (2021)

Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer
por: Chen, Yuanbin, et al.
Publicado: (2021)

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
por: Fan, Zhongyuan, et al.
Publicado: (2019)

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
por: Shahbaz, Muhammad, et al.
Publicado: (2020)

Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
por: Song, Yuxuan, et al.
Publicado: (2020)

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database
por: Jin, Kun, et al.
Publicado: (2021)

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer
por: Li, Shuaishuai, et al.
Publicado: (2022)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tn6r85h6vfos2bq74b877egqm6